Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients
出版年份 2018 全文链接
标题
Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-16
DOI
10.1007/s00280-018-3702-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer
- (2016) Hugh Giovinazzo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
- (2015) Huali Wu et al. International Journal of Nanomedicine
- Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
- (2015) Gina Song et al. Nanomedicine-Nanotechnology Biology and Medicine
- Steroid biosynthesis in adipose tissue
- (2015) Jiehan Li et al. STEROIDS
- Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents
- (2013) Ryan F. Schell et al. Nanomedicine-Nanotechnology Biology and Medicine
- The Role of Obesity in Cancer Survival and Recurrence
- (2012) W. Demark-Wahnefried et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Abstract 754: The effect of CC chemokine ligand-2 (CCL2/MCP-1) and CC chemokine ligand-5 (CCL5/RANTES) on the pharmacokinetics (PK) and the pharmacodynamics (PD) of pegylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors
- (2012) Gina Song et al. CANCER RESEARCH
- Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
- (2012) W P Caron et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)
- (2012) G. Song et al. EUROPEAN JOURNAL OF CANCER
- The inflammation highway: metabolism accelerates inflammatory traffic in obesity
- (2012) Amy R. Johnson et al. IMMUNOLOGICAL REVIEWS
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2012) Jennifer J. Griggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
- (2012) Gina Song et al. JOURNAL OF LIPOSOME RESEARCH
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2011) Huali Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2009) W C Zamboni et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Obesity and Breast Cancer: The Estrogen Connection
- (2009) Margot P. Cleary et al. ENDOCRINOLOGY
- Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
- (2008) W. C. Zamboni ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More